Critical Treatment of Coronary Artery Disease
NCT03195621 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-04-14
Summary
Identifying the critical lesion of coronary artery disease and determining the interventional plan are significant for reducing adverse cardiovascular adverse events. The assessment of critical lesion requires the consideration of plaque morphology, tissue composition, and endometrial stress which leading to rupture. In summary, accurate assessment of critical lesions has high application value. In this study, patients with critical coronary artery disease were divided into two groups: an accurate assessment group and a simple assessment group, with the aim to compare the diagnosis and treatment efficiency as well as prognosis, potential cardiovascular risk, possible "excessive" intervention.
Conditions
- Coronary Artery Disease
- Coronary Artery Disease Progression
Interventions
- DEVICE
-
Stent implantation
Stent placement after risk factors assessment plus FFR or ultrasound or OCT detection for critical lesions.
Sponsors & Collaborators
-
Science and Technology Department of Jiangsu Province
collaborator UNKNOWN -
Southeast University, China
lead OTHER
Principal Investigators
-
Gen-shan Ma, Ph.D · Southeast University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-01
- Primary Completion
- 2018-06-30
- Completion
- 2019-06-30
Countries
- China
Study Locations
More Related Trials
-
Drug-coated Balloon Versus Drug-eluting Stent in the Treatment of Coronary Artery Lesions in STEMI Patients in De Novo Coronary Lesions
NCT04072081 ·Status: UNKNOWN ·Phase: NA
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization
NCT06013007 ·Status: COMPLETED ·Phase: NA
-
Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation
NCT03375528 ·Status: UNKNOWN ·Phase: NA
-
OCT Based Edge and In-stent Vascular Response After Cordimax Stent in patIents With NSTE-ACS
NCT02868203 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
NCT01637012 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions
NCT01747356 ·Status: COMPLETED ·Phase: NA
-
China Resolute Integrity 34/38 mm Study
NCT03118531 ·Status: COMPLETED ·Phase: NA
-
Primary FIbrinolysis and Secondary STenting Versus immEdiate Stenting in ST-segment Elevation Myocardial Infarction
NCT04663932 ·Status: UNKNOWN ·Phase: NA
-
Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Stent Implantation
NCT02272283 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease
NCT04825886 ·Status: COMPLETED
-
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction
NCT06742125 ·Status: RECRUITING ·Phase: NA
-
Genetics Study of In-stent Restenosis
NCT01670396 ·Status: UNKNOWN
-
Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)
NCT02452736 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
NCT00691314 ·Status: COMPLETED ·Phase: NA
-
Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis
NCT00811772 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease
NCT03376646 ·Status: COMPLETED ·Phase: NA
-
A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly
NCT06168422 ·Status: RECRUITING
-
Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )
NCT04119986 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI
NCT03911895 ·Status: UNKNOWN
-
China Made Sirolimus Eluting Stent for Intermediate Lesion
NCT01375296 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
NCT00332397 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Multicenter Post Approval Study to Evaluate the Long-term Safety and Efficacy of the Resolute Integrity in the Japanese All-comers Patients With Coronary Artery Disease (PROPEL)
NCT01808391 ·Status: COMPLETED
-
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
NCT01078051 ·Status: TERMINATED ·Phase: PHASE4
-
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
NCT03201432 ·Status: COMPLETED ·Phase: PHASE2/PHASE3